Hydrogenation ring-opening method for biaromatic lactam and axially chiral compound prepared by hydrogenation ring-opening method
Through the combination of nickel catalyst and bisphosphine ligand, an efficient amide hydrogenation reaction under mild conditions is achieved, which solves the problems of high temperature, high pressure and high cost in the prior art, improves the reaction conversion and yield, and produces a wide range of results. Axial chiral compounds used.
Patent Information
- Application Number
- CN202310557339.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2024-11-26
AI Technical Summary
The existing amide hydrogenation reaction requires high temperature and high pressure conditions, the catalyst costs are high, and there are environmental risks, and the reaction selectivity is low, making it difficult to achieve high conversion and high yield amide hydrogenation.
A complex catalyst that binds nickel catalyst with bisphosphine ligand is used to promote the C-N bond of bisphosphine lactam under mild conditions to promote the hydrolysis of the C-N bond of bisphosphine lactam to form an axial chiral compound.
It reduces the reaction cost and safety risks, improves the conversion and yield of amide hydrogenation reaction, provides a new amide bond activation strategy, and produces axial chiral compounds with wider application prospects.
Smart Images

Figure CN119019267A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of organic synthesis, and in particular to a method for hydrogenating and ring-opening a biaryl lactam and an axial chiral compound prepared by the method. Background Art
[0002] As a common functional group, amide can act as an important intermediate or reactant to participate in a variety of reactions, such as nucleophilic substitution reaction, condensation reaction, elimination reaction, etc., to synthesize target compounds. However, in more than a century of amide transformation chemistry research, people have found that the existence of amide bonds Figure 1 The stable resonance structure shown makes the electrophilicity of its carbonyl group lower than that of other carboxylic acid derivatives, indicating that the chemical reaction in which the amide participates requires higher temperature, time, concentration and other conditions. Although there are biological enzymes in nature that can "cut" the CN bond of amide, this reaction usually needs to be carried out under specific conditions, such as specific temperature, pH, ionic strength, etc. For this reason, people hope to complete the activation of the amide bond through chemical synthesis methods to achieve selective reactions of the amide bond.
[0003] However, in the field of organic chemistry, it is very difficult to activate amide bonds with high selectivity and convert them into other organic compounds. Among them, a series of studies used green and atom-economical hydrogen as a hydrogenating agent to reduce the carbonyl carbon atom in the amide bond, which avoided the production of a large number of by-products compared to other hydrogenating agents. However, the activation of amide bonds using hydrogen as a reducing agent still faces two major challenges: one is that the reaction conditions are relatively severe, such as a hydrogen pressure of 200-300 bar and a reaction temperature greater than 200°C; the other is the chemical selectivity of amide hydrogenation, such as Figure 2 As shown in Figure 1, there are two competing reactions: direct hydrogenation of the carbonyl group (path A) and "cutting" hydrogenation of the CN bond (path B). Therefore, it is of great significance to develop amide hydrogenation reactions with high chemical selectivity under mild conditions.
[0004] Among them, the choice of reaction substrate and catalyst directly affects the reaction conditions, reaction mechanism, properties of intermediates, etc., and plays a vital role in the entire chemical reaction. In the amide hydrogenation reaction, the chemical reaction mechanism that occurs under alkaline or neutral conditions using chain or cyclic reaction substrates and homogeneous metal catalysts is as follows: Figure 3 As shown, Figure 4 A series of catalysts for amide activation are listed.
[0005] Generally speaking, the catalysts involved in amide hydrogenation generally use precious metals with high reactivity and selectivity. For example, in 2003, the first homogeneous catalytic amide hydrogenation reaction was reported, which used a catalytic system of ruthenium and tridentate phosphine ligands. In 2009, Ikariya and his collaborators first reported the hydrogenation ring opening of lactam substrates with protective groups on nitrogen to obtain amino alcohols. The reaction used [Ru-PN] bidentate complex as catalyst and an equivalent amount of potassium tert-butoxide as base. Two years later, Ikariya's group reported the use of improved [Ru-PN] bidentate complexes to achieve hydrogenation ring opening of unprotected cyclic lactams and two amides. A catalytic amount of base was used in this reaction. In 2010, Milstein's research group achieved an important breakthrough in this field, using pincer metal complexes to complete the hydrogenation of a wide range of secondary and tertiary amides at 110°C. In 2017, Bergens' group used chiral derivatives of Noyori-type complexes and stoichiometric sodium isopropoxide and isopropanol to realize the dynamic kinetic resolution process of deamination and hydrogenation of α-phenoxy tertiary amides for the first time, and successfully obtained alcohol compounds with good enantioselectivity. In 2018, Tu et al. used commercially available [Ru-MACHO-BH] complex as an active catalyst and catalytic amount of K3PO4 as a base to realize the deamination and hydrogenation of lactams with and without protecting groups. Also in 2018, Milstein and his collaborators reported the hydrogenation of secondary and tertiary amides using [Ru-PNN] pincer metal complexes and catalytic amounts of bases at room temperature and 5-10 bar hydrogen pressure. However, the above catalysts are expensive, and some of them also have toxicity and environmental risks.
[0006] Therefore, people began to try to use low-toxic, high-natural-abundance, cheap metals such as iron and manganese as metal catalysts to participate in the hydrogenation of amides. For example, in 2016, Milstein and his collaborators reported the first iron-catalyzed hydrogenation of amides, in which the active catalytic complex was generated by [Fe-PNP] complex as a precatalyst and the addition of a catalytic amount of KHMDS. After that, the Langer, Sanford and Bernskoetter groups reported iron complexes with similar structures and used them for the deamination and hydrogenation of secondary and tertiary amides without the addition of bases.
[0007] However, the above catalyst-mediated amide hydrogenation ring-opening reaction usually requires high temperature and high pressure conditions, a long reaction time, and low catalytic activity, which easily leads to reaction stagnation or low conversion rate, limiting the generation of amide hydrogenation reaction products. Therefore, it is particularly important to develop an amide hydrogenation method with high conversion rate and high yield. Summary of the invention
[0008] The purpose of the present invention is to overcome the shortcomings of the prior art and solve at least one defect in the above-mentioned background technology.
[0009] To achieve the above object, the present invention provides the following technical solutions:
[0010] The first aspect of the present invention provides a method for hydrogenating and ring-opening a biaryl lactam, comprising: S1, dissolving a nickel-containing catalyst and a diphosphine ligand in a solvent to prepare a complex catalyst; S2, mixing the biaryl lactam, a base and the complex catalyst, and introducing hydrogen into the mixture for reaction.
[0011] In one embodiment, in step S2, the structural formula of the biaryl lactam is as follows Figure 5 As shown in any of items 1a to 1f.
[0012] In one embodiment, in step S1, the nickel-containing catalyst is bis(1,5-cyclooctadiene)nickel.
[0013] In one embodiment, in step S1, the bisphosphine ligand is di(di-tert-butylphosphino)pyridine, [1,1′-binaphthyl]-2,2′-bisdiphenylphosphine, di(diphenylphosphino)phenylethylene, 2-(tert-butylamino)-9,10-diphenylnaphtho[2,1-a]phenanthran-11-phosphine, (1,6)-bis(diphenylphosphino)hexane, 2-(di-tert-butylphosphino)biphenyl and / or 2-(di-tert-butylphosphino)-2',4',6',8'-tetramethylbiphenyl.
[0014] In one embodiment, in the step S1, the molar ratio of the nickel-containing catalyst to the diphosphine ligand is 5:6.
[0015] In one embodiment, in step S2, the base is sodium bis(trimethylsilyl)amide.
[0016] In one embodiment, in step S2, the pressure of the hydrogen is 60-100 bar.
[0017] In one embodiment, in step S2, the reaction temperature is 80-100°C.
[0018] The second aspect of the present invention provides an axial chiral compound, wherein the axial chiral compound is prepared by the method of hydrogenation ring opening of the biaryl lactam.
[0019] In one embodiment, the structural formula of the axial chiral compound is as follows Figure 6 As shown in any one of items 2a to 2f.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] (1) The present invention uses cheap metal nickel as a catalyst. Compared with other catalysts with complex structures and difficult synthesis, it can reduce the production cost and improve the conversion rate and yield of the amide hydrogenation reaction.
[0022] (2) The present invention discloses for the first time a strategy of utilizing the ring tension of the cyclic lactam itself to promote the hydrogenation and cleavage of the amide CN bond, which not only provides a new idea for the activation of the amide bond, but also further improves the conversion rate and yield of the amide hydrogenation reaction.
[0023] (3) The reaction conditions adopted in the present invention are relatively mild, which is helpful for controlling the reaction process and improving the stability, and can also reduce the cost and safety risks of the reaction equipment, thereby improving the sustainability and economy of the reaction process.
[0024] (4) The axial chiral compound prepared by the present invention contains two useful functional groups, amino and hydroxyl, and can undergo a variety of reactions such as nucleophilic addition, esterification, condensation, and hydroxylation. It is easier to play a role in organic synthesis, has a wider application prospect, and can obtain more complex compounds. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 These are two resonance structure diagrams of amide compounds;
[0026] Figure 2 is the reaction mechanism diagram of the amide hydrogenation process;
[0027] Figure 3 The reaction mechanism diagram of the amide hydrogenation process of different reaction substrates;
[0028] Figure 4 is a structural diagram of a catalyst for amide activation;
[0029] Figure 5 is the structural formula of the biaryl lactam in one embodiment;
[0030] Figure 6 is the structural formula of the axial chiral compound in one embodiment;
[0031] Figure 7 is a reaction mechanism diagram of hydrogenation ring opening of biaryl lactam in one embodiment;
[0032] Figure 8 A diagram showing the synthesis mechanism of biaryl lactam in an embodiment;
[0033] Fig. 9 is a structural diagram of a biaryl lactam in an embodiment;
[0034] Fig.10 is a reaction mechanism diagram of hydrogenation ring opening of biaryl lactam under different ligands in one embodiment;
[0035] Fig.11 A diagram showing the structure of a chiral ligand in one embodiment;
[0036] Fig.12 is a structural diagram of a non-chiral ligand in an embodiment;
[0037] Fig.13 A reaction mechanism diagram of hydrogenation ring-opening of biaryl lactam under different catalysts and bases in one embodiment;
[0038] Fig.14 is a reaction mechanism diagram of using phenylsilane as a hydrogenating agent in one embodiment;
[0039] Fig.15 FIG. 1 is a mechanism diagram of the reaction using biaryl lactam 1g in an embodiment. DETAILED DESCRIPTION
[0040] The technical solution of this patent will be further described in detail below in conjunction with specific implementation methods. It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of this application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by ordinary technicians in the technical field to which this application belongs.
[0041] The reaction substrate of this scheme, biaryl lactam, refers to a compound in which an amide functional group (-CONH-) forms a ring structure with two adjacent carbon atoms on a benzene ring, which is also commonly referred to as lactam or aromatic lactam. This compound has high stability and biological activity, and therefore has been widely used in the fields of drug research and biochemistry. In drug research, biaryl lactam can be used as the skeleton structure of drug molecules to regulate the biological activity and pharmacokinetic properties of drugs by changing the substitution site and type of functional groups. In biochemistry, biaryl lactam can be degraded by enzyme-catalyzed reactions, thereby playing a role in regulating enzyme activity and signal transduction.
[0042] The reaction product of this scheme, an axial chiral compound, refers to a compound in which there is an axially symmetrical element in the molecule, which makes the molecule mirror-symmetrical on both sides along the axis, but the molecule as a whole cannot achieve complete symmetry through rotation. The molecular structure of this compound has dual symmetry, that is, the molecule can rotate 180 degrees around the axis without losing symmetry, but cannot rotate around other axes. This compound is usually obtained through a series of chemical reactions of a compound containing two functional groups (such as amino and hydroxyl groups) and has certain spatial isomerism. Therefore, it has many important applications in chemistry and biology, especially in drug synthesis and chiral catalytic reactions. For example, axial chiral compounds can improve the bioavailability and selectivity of drugs in drug synthesis, thereby reducing side effects and toxicity; in chiral catalytic reactions, axial chiral compounds can be used as chiral recognition groups to improve reaction rates and selectivity.
[0043] The invention provides a method for hydrogenation ring opening of biaryl lactams, which uses green and economical hydrogen as a hydrogenation reagent, uses cheap metal nickel as a catalyst, cooperates with a bisphosphine ligand, and utilizes the ring tension of the lactam to achieve hydrogenation cracking ring opening of the CN bond of the biaryl lactam compound, thereby constructing an axial chiral compound containing both an amino group and a hydroxyl group.
[0044] like Figure 7 As shown, the method for hydrogenating and ring-opening the biaryl lactam comprises: S1, dissolving a nickel-containing catalyst and a diphosphine ligand in a solvent to prepare a complex catalyst; S2, mixing the biaryl lactam, a base and the complex catalyst, and introducing hydrogen into the mixture for reaction.
[0045] In one embodiment, in step S2, the structural formula of the biaryl lactam is as follows Figure 5 As shown in any of items 1a to 1f.
[0046] In one embodiment, in step S1, the nickel-containing catalyst is bis(1,5-cyclooctadiene)nickel (Ni(COD)2).
[0047] In one embodiment, in step S1, the bisphosphine ligand is di(di-tert-butylphosphino)pyridine (DCYPE), [1,1′-binaphthyl]-2,2′-bisdiphenylphosphine ((Rac)-BINAP), di(diphenylphosphino)phenylethylene (DPPBE), 2-(tert-butylamino)-9,10-diphenylnaphtho[2,1-a]phenanthran-11-phosphine (XantPhos), (1,6)-bis(diphenylphosphino)hexane ((1,6)-Bis(diphenylphosphino)hexane), 2-(di-tert-butylphosphino)biphenyl (JohnPhos) and / or 2-(di-tert-butylphosphino)-2',4',6',8'-tetramethylbiphenyl (X-Phos).
[0048] In one embodiment, in the step S1, the molar ratio of the nickel-containing catalyst to the diphosphine ligand is 5:6.
[0049] In one embodiment, in step S2, the base is sodium bis(trimethylsilyl)amide (NaHMDS).
[0050] In one embodiment, in step S2, the pressure of the hydrogen is 60-100 bar.
[0051] In one embodiment, in step S2, the reaction temperature is 80-100°C.
[0052] The present invention also provides an axial chiral compound, which is prepared by the method of hydrogenating and ring-opening the biaryl lactam.
[0053] In one embodiment, the structural formula of the axial chiral compound is as follows Figure 6 As shown in any one of items 2a to 2f.
[0054] The present invention will be further described below through specific experimental examples.
[0055] Example 1: Synthesis of biaryl lactam
[0056] The general reaction formula for preparing biaryl lactam 1 using aryl o-bromocarboxylic acid A as raw material is as follows: Figure 8 The specific steps are as follows:
[0057] (1) Preparation of acyl chloride B. Place a magnetic particle in a 100 mL round-bottom bottle with a branch, add aromatic o-bromocarboxylic acid A (10 mmol), cover with a rubber stopper, and replace the nitrogen in the reaction system three times using a double-row system. Then, add 40 mL of anhydrous dichloromethane to the reaction bottle to dissolve the reaction raw materials under stirring. Then, place the reaction bottle in a 0°C ice bath, and add oxalyl chloride (12 mmol, 1.0 mL) dropwise to the reaction system with a syringe while stirring. After the addition is complete, add two to three drops of N,N-dimethylformamide (DMF) to the reaction system to generate a large number of bubbles. After the reaction system reacts at 0°C for 30 minutes, it is placed at room temperature to react overnight. The final reaction solution will change from turbid to yellow and clear. After the reaction is completed, the reaction solution is spin-dried to obtain a yellow solid, which is washed with dichloromethane and then spin-dried and used directly in the next step.
[0058] (2) Preparation of compound C. Prepare a 200 mL round-bottom bottle with a branch, put in a magnetic bar, add arylamine (10 mmol) and 4-dimethylaminopyridine (DMAP, 0.5 mol%, 0.05 mmol, 6.1 mg), cover with a rubber stopper, connect to a double-row system, and replace nitrogen in the reaction system three times. Then, add triethylamine (NEt3, 20 mmol, 2.8 mL) and 40 mL of anhydrous tetrahydrofuran (THF) to the reaction bottle, stir evenly, and place the reaction bottle in an ice bath at 0°C. At the same time, dissolve the acyl chloride B prepared in step (1) in 20 mL of anhydrous tetrahydrofuran, and then use a syringe to dropwise add the tetrahydrofuran solution of the acyl chloride into the reaction bottle. After reacting for 30 minutes, place it at room temperature to react, and monitor the reaction by a thin layer chromatography plate. After the reaction, 40 mL of 5% aqueous hydrochloric acid was added to quench the reaction, and the reaction solution was extracted 3 times with 20 mL of ethyl acetate. The extracted organic phase was washed twice with saturated brine, and the organic phase was dried over anhydrous sodium sulfate and spin-dried to obtain a relatively pure product, which was directly used in the next step without column chromatography.
[0059] (3) Preparation of compound D. Prepare a 100 mL round-bottom reaction bottle with a branch, add a magnetic rod, weigh the compound C (8 mmol) obtained in step (2), cover it with a rubber stopper, connect a double row, and replace the nitrogen in the reaction system three times. Then, add 40 mL of anhydrous tetrahydrofuran to the reaction bottle, stir it evenly, put the reaction bottle in a 0°C ice bath, blow nitrogen, add sodium hydride (60% in oil, 16 mmol, 640 mg) to the reaction bottle, and react for 1 hour. Then, add iodomethane (16 mmol) or benzyl bromide (16 mmol) to the reaction system, react for 30 minutes, and then transfer to room temperature for reaction. Monitor the reaction by thin layer chromatography. After the reaction is completed, add 50 mL of saturated brine to quench the reaction, use 20 mL of ethyl acetate to extract three times, dry with anhydrous sodium sulfate, spin dry, and pass through a silica gel column, wherein the eluent polarity is petroleum ether / ethyl acetate (50 / 1 to 10 / 1), to obtain compound D.
[0060] (4) Preparation of reaction substrate 1. Prepare a 100 mL round-bottom reaction bottle with a branch, add a magnetic rod, weigh in the compound D (3 mmol) obtained in step (3), cover with a rubber stopper and put into a glove box. In the glove box, weigh in tetrakis(triphenylphosphine)palladium (Pd(PPh3)4, 10 mol%, 0.3 mmol, 346.7 mg) and potassium acetate (KOAc, 6 mmol, 588.8 mg) into the reaction bottle, cover with a rubber stopper and leave the glove box. Then, add 15 mL of anhydrous N,N-dimethylformamide to the reaction bottle, insert a nitrogen balloon into the rubber stopper, put the reaction bottle into a pre-prepared 100°C oil bath, react for 12 h, and monitor the reaction with a plate. After the reaction, the room temperature was restored, 30 mL of saturated brine was added, and the mixture was extracted four times with 10 mL of ethyl acetate. The organic phase was then washed once with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and passed through a silica gel column, wherein the eluent polarity was petroleum ether / ethyl acetate (50 / 1 to 8 / 1).
[0061] Results: Fig. 9 As shown, a total of 7 lactam substrates were obtained, and their NMR characterization data are as follows.
[0062] NMR data of reaction substrate 1a:
[0063] 1 HNMR (400MHz, CDCl3): δ=2.24(s,3H),2.54(s,3H),3.78(s,3H),7.07(s,1H),7.14(s,1 H),7.51-7.55(m,1H),7.59-7.63(m,1H),7.93-7.97(m,3H),8.45(d,J=8.0Hz,1H)ppm;
[0064] 13 CNMR (100MHz, CDCl3): δ = 21.8, 24.4, 30.6, 112.0, 116.7, 123.4, 125.4, 125.5, 127. 0,127.6,127.8,127.9,129.0,129.3,133.2,135.0,136.7,138.8,139.0,162.1ppm.
[0065] NMR data of reaction substrate 1b:
[0066] 1HNMR (400MHz, CDCl3): δ = 2.24 (s, 3H), 2.39 (s, 3H), 5.44 (d, J = 16.0Hz, 1H), 5.86 (d, J = 16.0Hz, 1H), 7.04 (d, J = 12.0 Hz,2H),7.22-7.31(m,6H),7.53-7.57(m,1H),7.61-7.65(m,1H),7.98(t,J=8.0Hz,3H),8.52(d,J=8.0Hz,1H)ppm;
[0067] 13 CNMR (100MHz, CDCl3): δ=21.8,24.5,46.6,113.0,116.9,123.7,125.2,125.4,126.6,127.1,1 27.7,127.9,128.7,129.0,129.3,130.7,133.5,135.2,136.7,137.0,138.4,138.6,162.1ppm.
[0068] NMR data of reaction substrate 1c:
[0069] 1 HNMR (400MHz, CDCl3): δ = 3.83 (s, 3H), 7.57-7.61 (m, 1H), 7.53-7.57 (m, 1H), 7.65-7.69 (m, 1H), 7.83 (s, 1H), 7.88(s,1H),7.98(d,J=8.0Hz,1H),8.09(d,J=12.0Hz,1H),8.25(d,J=8.0Hz,1H),8.40(d,J=8.0Hz,1H)ppm;
[0070] 13 CNMR(100MHz, CDCl3): δ=30.7,113.6(m,J CF =Hz),118.6,119.1,122.6,126.6(q,J CF =3.0Hz),126.8,126.9,127.9,128.4,130.4,130.9,134.4,139.2,161.5ppm;
[0071] 19 FNMR (376MHz, CDCl3): δ = -62.6, -54.2ppm.
[0072] NMR data of reaction substrate 1d:
[0073] 1HNMR (400MHz, CDCl3): δ = 2.29 (s, 3H), 3.84 (s, 3H), 7.44-7.54 (m, 2H), 7.58 (t, J = 6.0Hz, 1H), 7.64 (t, J = 8 .0Hz,2H),7.78(d,J=8.0Hz,1H),7.91(d,J=8.0Hz,1H),8.00(d,J=12.0Hz,1H),8.44(d,J=8.0Hz,1H)ppm;
[0074] 13 CNMR (100MHz, CDCl3): δ=23.9,30.6,113.9,114.4,124.5,125.7,126.2,127.1,1 27.7,127.8,128.5,129.3,129.8,130.0,133.1,135.0,135.3,136.4,162.7ppm.
[0075] NMR data of reaction substrate 1e:
[0076] 1 HNMR (400MHz, CDCl3): δ = 2.19 (s, 3H), 2.40 (s, 3H), 3.91 (s, 3H), 5.43 (d, J = 16.0Hz, 1H), 5.90 (d, J = 16.0Hz, 1H), 7.11 (s, 1H), 7.2 3-7.34(m,5H),7.57(t,J=6.0Hz,1H),7.66(t,J=8.0Hz,1H),7.96(d,J=8.0Hz,1H),8.00-8.04(m,2H),8.55(d,J=8.0Hz,1H)ppm;
[0077] 13 CNMR (100MHz, CDCl3): δ=17.0,19.3,46.5,60.3,115.0,118.6,123.7,125.49,125.54,126.6,127.1,1 27.7,128.0,128.1,128.8,129.07,129.1,129.4,132.2,133.3,134.5,135.2,137.0,154.0,162.0ppm.
[0078] NMR data of reaction substrate 1f:
[0079] 1HNMR (400MHz, CDCl3): δ = 2.39 (s, 3H), 2.43 (s, 3H), 2.46 (s, 3H), 3.66 (s, 3H), 6.98 (d, J=12.0Hz,2H),7.45(t,J=8.0Hz,1H),7.53(d,J=8.0Hz,1H),8.30(d,J=8.0Hz,1H)ppm;
[0080] 13 CNMR (100MHz, CDCl3): δ=21.7,21.8,22.0,30.4,111.6,117.4,125.3,126.0,126.7,128.4,133.8,134.1,134.9,136.3,138.1,138.5,162.5ppm.
[0081] NMR data of reaction substrate 1g:
[0082] 1 HNMR (400MHz, CDCl3): δ = 3.8 (s, 3H), 7.31 (d, J = 8.0Hz, 1H), 7.40 (d, J = 8.0Hz, 1H), 7.51-7.59(m,1H),7.72-7.76(m,1H),8.24-8.27(m,2H),8.55(d,J=8.0Hz,1H)ppm;
[0083] 13 CNMR (100MHz, CDCl3): δ=30.0,115.0,119.3,121.6,122.4,123.2,125.6,127.9,128.9,129.6,132.4,133.5,138.0,161.6ppm.
[0084] Example 2: Screening of ligands
[0085] like Fig.10 As shown, the biaryl lactam synthesized in Example 1 is used as the reaction substrate 1a, bis(1,5-cyclooctadiene) nickel (Ni(COD)2) is used as a catalyst, sodium bis(trimethylsilyl)amide (NaHMDS) is used as a base, and hydrogen is used as a hydrogenation agent to prepare an axial chiral compound to screen a suitable ligand L. Wherein, the ligand L includes Fig.11 The six chiral ligands shown and Fig.12 The seven non-chiral ligands shown are used as controls to set up a group without adding ligands. The specific steps are as follows:
[0086] (1) Complexation preparation of catalyst. In a glove box with argon atmosphere, bis(1,5-cyclooctadiene)nickel (5 mol%, 0.01 mmol, 2.8 mg) was weighed into a 5 mL hydrogenation vial containing a magnetic rod, and then ligand L (6 mol%, 0.012 mmol) was weighed into the vial, 1 mL of anhydrous toluene was added, and the mixture was stirred at room temperature for 10 min.
[0087] (2) Hydrogenation reaction. The reaction substrate 1a (0.2 mmol, 57.5 mg) and sodium bis(trimethylsilyl)amide (1.2 eq., 0.24 mmol, 44 mg) were weighed into the reaction vial containing the prepared catalyst, and then the reaction hydrogenation vial was placed in a high-pressure reactor and the lid was tightened. After leaving the glove box, the lid was further tightened with a wrench, the hydrogen pipeline was connected, the hydrogen was replaced into the reactor three times, and then 60 bar of hydrogen was filled, and the side branch ventilation port was tightened. Finally, the reactor was placed in an 80°C oil bath for reaction for 24 hours.
[0088] (3) Post-treatment. After the reaction is completed, lift the reactor out of the oil bath and wait for it to return to room temperature. Release the hydrogen in the reactor in a fume hood, unscrew the lid of the reactor with a wrench, and take out the hydrogenation reaction vial. The reaction solution is spin-dried and the product is separated and purified by silica gel column chromatography. The eluent is petroleum ether / ethyl acetate (10:1). The product is a light yellow solid.
[0089] (4) The enantiomeric excess (Ee) of the chiral ligand group is required to measure the enantiomeric selectivity of the reaction. The specific test method is as follows: the racemic product sample is split using a high performance liquid chromatography containing a chiral chromatographic column. After the splitting is successful, the reaction product with the addition of the chiral ligand group is tested using the splitting conditions, and the enantiomeric excess is calculated by the liquid phase peak area.
[0090] Among them, the chiral separation conditions of the product 2a of the hydrogenation ring-opening of the reaction substrate 1a are as follows: the chiral column is a Dasero AD-H chiral column, the mobile phase polarity is n-hexane / isopropanol (70:30), the flow rate is 1 mL / min, the column temperature is 25°C, and the detection wavelength is 210 nm.
[0091] Results: Table 1 shows the conversion rate, yield and enantiomeric excess values of six groups of chiral ligands under the reaction of different ligands L, among which Group 1 is the control group without adding ligand, Groups 2-7 are chiral ligand groups, and Groups 8-14 are achiral ligand groups.
[0092] It can be seen that after adding the ligand, the conversion rate of the reaction increased, and the yield was mostly higher than that of the group without adding the ligand. In addition, the enantiomeric excess value Ee of the chiral ligand group is 0, that is, the content of various enantiomers in the enantiomeric mixture is equal. In this case, the rotations of different enantiomers cancel each other out, and the optical device cannot show optical activity. Therefore, the enantiomeric mixture does not have chirality, that is, the enantioselectivity of the product cannot be controlled. Among the achiral ligands, the group 11 using DCYPE as a ligand has a higher conversion rate and yield. Therefore, compared with iron, manganese and other catalysts, the complex catalyst prepared by nickel catalyst and bisphosphine ligand mediated amide hydrogenation reaction achieved higher conversion rate and yield.
[0093] Table 1 Ligand screening
[0094]
[0095]
[0096] Example 3: Screening of other reaction conditions
[0097] Same as Example 2, DCYPE was used as the ligand, and some conditions were changed. Fig.13 The specific conditions of the reaction are shown in Table 2. The operation steps of Groups 15-21 are the same as steps (1)-(3) in Example 2. Group 22, i.e., using phenylsilane instead of hydrogen as the hydrogenation reagent, performs the following steps:
[0098] Add a magnet to a 10mL Schlenk reaction tube with a branch, weigh the reaction substrate 1a (0.1mmol, 28.8mg), NiCl2·DME (10mol%, 0.01mol, 2.2mg), and seal it with a rubber stopper. After replacing nitrogen three times in a double-row system, add phenylsilane (0.2mmol, 21.6mg, 24.7μL) and 1mL of anhydrous toluene to the reaction tube using a microsyringe, replace the rubber stopper with a tetrafluoroethylene screw stopper under nitrogen, and finally put the reaction tube into a pre-prepared 115℃ oil bath pot for 24h. After the reaction is completed, spin dry the solvent, and separate and purify the product by silica gel column chromatography, and the eluent is petroleum ether / ethyl acetate (100:1).
[0099] Results: Table 2 shows the conversion rate and yield under different reaction conditions. In Group 15, no catalyst or base was added, and the reaction did not occur at this time; in Group 19, NaOtB was used to replace NaHMDS as the base, and no corresponding product was detected at this time; in Groups 20 and 21, the reaction temperature and hydrogen pressure were adjusted, and under these conditions, the conversion rate and yield of the amide hydrogenation reaction were both at a high level.
[0100] Based on the experimental results in Table 1 and Table 2, the optimal reaction conditions with high conversion rate and high yield were determined, namely, Ni(COD)2 (5 mol%) as catalyst, DCYPE (6 mol%) as ligand, NaHMDS (1.2 eq.) as base, H2 (60 bar) as reducing agent, anhydrous toluene (1 mL) as solvent, temperature of 80°C, and reaction time of 24 h.
[0101] Table 2 Screening of other reaction conditions
[0102]
[0103] In addition, if Fig.14 As shown, group 22 used phenylsilane as the hydrogenating agent to obtain the product 1x in which the carbonyl group was reduced, rather than the product of hydrogenation ring opening by cutting the CN bond.
[0104] NMR data of product 1x:
[0105] 1 HNMR (400MHz, CDCl3): δ = 2.16 (s, 3H), 2.43 (s, 3H), 2.93 (s, 3H), 3.92-4.05 (m, 2H), 6.60 (s, 1H), 6 .76(s,1H),7.37(d,J=8.0Hz,1H),7.40-7.44(m,2H),7.76(d,J=8.0Hz,2H),7.83-7.86(m,1H)ppm;
[0106] 13 CNMR (100MHz, CDCl3): δ = 21.8, 22.9, 39.0, 56.9, 110.7, 121.8, 123.2, 123.4, 124.9 ,125.2,126.8,127.2,128.1,129.1,129.6,133.5,135.8,136.2,137.9,151.0ppm.
[0107] Example 4: Expansion of other reaction substrates
[0108] In Examples 2 and 3, the reaction substrate 1a prepared in Example 1 was used to carry out amide hydrogenation reaction. In this Example, based on Example 3, other reaction substrates 1b-1g prepared in Example 1 were used to carry out the reaction. The specific operation steps are the same as steps (1)-(3) of Example 2.
[0109] Results: Table 3 shows the main reaction products and their corresponding yields when biaryl lactams 1a-1f are used as reaction substrates. The structural formulas of the reaction products are shown in Figure 6As can be seen from the table, the yield of the amide hydrogenation reaction using the reaction substrate represented by the structural formula 1a is the highest, the yield of the reaction substrate represented by the structural formula 1d is the second highest, and the yields of the remaining substrates are between 55-65%.
[0110] Table 3 Expansion of reaction substrates
[0111]
[0112] like Fig.15 As shown, when the biphenyl lactam substrate 1g with very small ring tension was used for the reaction, no product of ring opening by cutting the CN bond and hydrogenation was detected, but 34% of the carbonyl group was reduced and 9% of the imine by-products produced by dehydration of the reaction intermediate were detected. This shows that the ring tension of the lactam substrate is an important driving force for the reaction system to successfully achieve amide bond and CN bond hydrogenation cleavage rather than direct carbonyl reduction.
[0113] NMR data of reaction product 2a:
[0114] 1 H NMR (400MHz, CDCl3): δ = 1.74 (s, 3H), 2.42 (s, 3H), 2.63 (s, 3H), 4.44 (m, 2H), 6.54 (s, 1H), 6.6 8(s,1H),7.34-7.42(m,2H),7.46-7.50(m,1H),7.71(d,J=4.0Hz,1H),7.89-7.94(m,2H)ppm;
[0115] 13 C NMR (100MHz, CDCl3): δ = 19.9, 21.8, 31.0, 64.6, 109.6, 121.09, 121.12, 125.4, 126. 1,126.6,127.6,128.2,128.5,132.3,133.6,133.7,137.1,137.7,138.6,146.9ppm.
[0116] NMR data of reaction product 2b:
[0117] 1H NMR (400MHz, CDCl3): δ = 1.74 (s, 3H), 2.34 (s, 3H), 4.18 (q, J = 12.0Hz, 2H3H), 4.50 (m, 2H), 6.52 (s, 1H), 6.66 (s, 1H),7.07(d,J=8.0Hz,2H),7.14-7.22(m,3H),7.36-7.51(m,3H),7.72(d,J=8.0Hz,1H),7.88-7.93(m,2H)ppm;
[0118] 13 C NMR (100MHz, CDCl3): δ=19.9,21.8,48.0,64.4,110.3,120.8,121.1,125.4,126.1,126.5,126.95 ,126.98,127.2,128.2,128.4,128.6,132.2,133.3,133.7,137.3,137.7,138.5,139.1,145.5ppm.
[0119] NMR data of reaction product 2c:
[0120] 1 H NMR (400MHz, CDCl3): δ = 2.71 (s, 3H), 4.45 (m, 2H), 7.12 (s, 1H), 7.18 (d, J = 8.0Hz, 1H), 7.37-7.40 (m, 1H) ,7.46(s,1H),7.49-7.53(m,1H),7.79(d,J=8.0Hz,1H),7.91(d,J=8.0Hz,1H),8.02(d,J=8.0Hz,1H)ppm;
[0121] 13 C NMR (100MHz, CDCl3): δ = 30.6, 63.3, 109.3-109.4 (m), 111.1-112.3 (m), 125.1, 126.2, 126.4, 126.9, 128.0, 128.2, 130.0, 131.9, 137.9, 148.6ppm;
[0122] 19 F NMR (376MHz, CDCl3): δ = -63.1, -60.6ppm.
[0123] NMR data of reaction product 2d:
[0124] 1H NMR (400MHz, CDCl3): δ = 1.92 (s, 3H), 2.90 (s, 3H), 4.15-4.22 (m, 2H), 6.95-6.98 (m, 1H),, 7.23-7.29 (m, 4H) ,7.38-7.40(m,1H),7.44(t,J=8.0Hz,1H),7.51-7.52(m,1H),7.79-7.81(m,1H),7.89(d,J=8.0Hz,1H)ppm;
[0125] 13 C NMR (100MHz, CDCl3): δ=19.6,31.1,64.3,113.4,117.1,122.2,123.0,126.8,12 7.2,127.7,128.2,128.6,129.3,130.2,132.6,134.5,138.5,141.1,143.5ppm.
[0126] NMR data of reaction product 2e:
[0127] 1 H NMR (400MHz, CDCl3): δ = 1.72 (s, 3H), 2.33 (s, 3H), 3.71 (s, 3H), 4.14 (q, J = 12.0Hz, 2H), 4.48 (q, J = 12.0Hz, 2H), 6.53 (s, 1H), 6.66 (s, 1H),7.05(d,J=8.0Hz,2H),7.15-7.21(m,3H),7.37-7.42(m,2H),7.48-7.50(m,1H),7.72(d,J=4.0Hz,1H),7.90(q,J=4.0Hz,2H)ppm;
[0128] 13 C NMR (100MHz, CDCl3): δ=13.3,16.6,48.4,60.3,64.5,112.3,123.0,125.3,126.2,126.6,127.0,127 .1,127.5,128.3,128.5,128.7,130.4,130.9,132.1,133.2,133.7,137.6,139.1,141.6,149.9ppm.
[0129] NMR data of the reaction product 2f:
[0130] 1H NMR (400MHz, CDCl3): δ = 1.81 (s, 3H), 1.96 (s, 3H), 2.35 (s, 3H), 2.71 (s, 3H), 4. 22(s,2H),6.46(s,1H),6.59(s,1H),7.27-7.33(m,2H),7.38-7.40(m,1H)ppm;
[0131] 13 C NMR (100MHz, CDCl3): δ=19.6,19.7,21.7,31.0,64.5,109.6,121.1,122.5,127.3,128.2,130.1,135.9,136.0,137.5,138.2,140.2,145.6ppm.
[0132] In summary, the present invention provides a method for hydrogenation ring opening of biaryl lactam and an axial chiral compound prepared by the method. The method uses biaryl lactam as a substrate, bis(1,5-cyclooctadiene) nickel co-ligand as a catalyst, hydrogen as a hydrogen source, sodium bis(trimethylsilyl)amide as a base, toluene as a solvent, and reacts in a high-pressure reactor, screens reaction conditions with high conversion rate and high yield, and obtains a method that can realize hydrogenation cracking ring opening of lactam CN bond and construct axial chiral compound.
[0133] The above are only some embodiments of the present invention. For those skilled in the art, several modifications and improvements can be made without departing from the creative concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A method for hydrogenating and ring-opening a biaryl lactam, characterized in that: The method comprises: S1, dissolving the nickel-containing catalyst and the diphosphine ligand in a solvent to prepare a complex catalyst; S2, mixing the biaryl lactam, the base and the complex catalyst, and introducing hydrogen into the mixture for reaction.
2. The method for hydrogenating and ring-opening a biaryl lactam according to claim 1, characterized in that: In the step S2, the structural formula of the biaryl lactam is shown in any one of the following formulas 1a to 1f:
3. The method for hydrogenating and ring-opening a biaryl lactam according to claim 2, characterized in that: In the step S1, the nickel-containing catalyst is bis(1,5-cyclooctadiene)nickel.
4. The method for hydrogenating and ring-opening a biaryl lactam according to claim 3, characterized in that: In step S1, the bisphosphine ligand is di(di-tert-butylphosphino)pyridine, [1,1′-binaphthyl]-2,2′-bisdiphenylphosphine, di(diphenylphosphino)phenylethylene, 2-(tert-butylamino)-9,10-diphenylnaphtho[2,1-a]phenanthran-11-phosphine, (1,6)-bis(diphenylphosphino)hexane, 2-(di-tert-butylphosphino)biphenyl and / or 2-(di-tert-butylphosphino)-2′,4′,6′,8′-tetramethylbiphenyl.
5. The method for hydrogenating and ring-opening a biaryl lactam according to claim 4, characterized in that: In the step S1, the molar ratio of the nickel-containing catalyst to the diphosphine ligand is 1:1-1.
5.
6. The method for hydrogenating and ring-opening a biaryl lactam according to any one of claims 1 to 5, characterized in that: In the step S2, the base is sodium bis(trimethylsilyl)amide.
7. The method for hydrogenating and ring-opening a biaryl lactam according to claim 6, characterized in that: In step S2, the pressure of the hydrogen is 60-100 bar.
8. The method for hydrogenating and ring-opening a biaryl lactam according to claim 7, characterized in that: In the step S2, the reaction temperature is 80-100°C.
9. An axial chiral compound, characterized in that The axial chiral compound is prepared by the method for hydrogenating and ring-opening the biaryl lactam according to any one of claims 1 to 8.
10. The axial chiral compound according to claim 9, characterized in that The structural formula of the axial chiral compound is shown in any one of the following formulas 2a to 2f:
